Table 2. Summary of BLS-M07 dose escalation.
BLS-M07 dose (mg) | No. of patients | DLTs* and treatment-related SAEs |
---|---|---|
500 | 4 | None |
1,000 | 3 | None |
1,500 | 3 | None, grade 1 premenstrual pain (2 patients) |
DLS, dose-limiting toxicity; SAE, severe adverse event.
*DLT: any drug related grade 3 or higher toxicities.